These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 30148689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
    Chiu SS, Feng S, Chan KH, Lo JY, Chan EL, So LY, Cowling BJ, Peiris JS.
    Vaccine; 2016 Apr 27; 34(19):2164-9. PubMed ID: 27013437
    [Abstract] [Full Text] [Related]

  • 6. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T, Kossyvakis A, Melidou A, Andreopoulou A, Exindari M, Gioula G, Kalliaropoulos A, Tryfinopoulou K, Pogka V, Spala G, Malisiovas N, Mentis A.
    J Med Virol; 2016 Nov 27; 88(11):1896-904. PubMed ID: 27088266
    [Abstract] [Full Text] [Related]

  • 7. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S, Pan Y, Zhang X, Zhang L, Duan W, Ma C, Zhang Y, Zhang M, Sun Y, Yang P, Wang Q, Ma J.
    Vaccine; 2018 Sep 11; 36(38):5774-5780. PubMed ID: 30087046
    [Abstract] [Full Text] [Related]

  • 8. Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.
    Stein Y, Mandelboim M, Sefty H, Pando R, Mendelson E, Shohat T, Glatman-Freedman A, Israeli Influenza Surveillance Network (IISN).
    Clin Infect Dis; 2018 Apr 17; 66(9):1383-1391. PubMed ID: 29145568
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
    Chan YW, Wong ML, Kwok FY, Au AK, Leung EC, Chuang SK.
    Vaccine; 2021 Jun 08; 39(25):3372-3378. PubMed ID: 34016472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20.
    Chiu SS, Chua H, Kwan MYW, Chan ELY, Wong JSC, Peiris JSM, Cowling BJ.
    Vaccine; 2020 Dec 03; 38(51):8078-8081. PubMed ID: 33168346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N, McMenamin J, Durnall H, Ellis J, Lackenby A, Robertson C, von Wissmann B, Cottrell S, Smyth B, Moore C, Gunson R, Zambon M, Fleming D, Pebody R.
    Euro Surveill; 2014 Jul 10; 19(27):5-13. PubMed ID: 25033051
    [Abstract] [Full Text] [Related]

  • 19. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I, Navascués A, Pozo F, Chamorro J, Albeniz E, Casado I, Reina G, Cenoz MG, Ezpeleta C, Castilla J, Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra.
    Hum Vaccin Immunother; 2015 Jul 10; 11(7):1626-33. PubMed ID: 25996366
    [Abstract] [Full Text] [Related]

  • 20. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, Horváth JK, Donnell JM, Pitigoi D, Machado A, Pozo F, I-MOVE Multicentre Case Control Study Team.
    Vaccine; 2015 Jun 04; 33(24):2813-22. PubMed ID: 25936723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.